Overview
Emmanuelle Trombe and Bertrand Delafaye led a Paris corporate and tax team of Aymeric Discours, Mathilde Peschard, Anaël Hadji, Stephan de Groër Antoine Vergnat and Côme de Saint-Vincent, which assisted DBV Technologies, a French biopharmaceutical company listed on Euronext Paris and Nasdaq, with a € 140.8 million public offering in the US, Canada and other countries as well as a private placement in Europe.
